Table 1.
Ref. | Study design | No. of patients | Disease cause/stage | Cell/harvest | Infusion route/n cell infused |
Park et al[69] | Case series | 5 | Mixed | MNCs (MSCs) | Hepatic artery |
Cytotherapy, 2013 | CTP B-C | BM aspiration | 106-107/kg | ||
Amin et al[64] | Case series | 20 | HCV | MSCs | Intrasplenic |
Clin Transplant, 2013 | CTP C | BM aspiration | 107 | ||
Mohamadnejad et al[57] | Randomized | 15 | Mixed | MSCs/placebo | Peripheral vein |
Liver Int, 2013 | Vs untreated control | 12 control | CTP A-C | BM aspiration | 108 |
Jang et al[59] | Case series | 12 | Alcohol | MSCs | Hepatic artery |
Liver Int, 2013 | CTP A-B | BM aspiration | 107 | ||
Salama et al[68] | Not-randomized | 50 | HCV | HSCs | Portal vein/hepatic artery |
Stem Cell Res Ther, 2012 | Vs untreated control | 50 control | ESLD | Leukapheresis | |
G-CSF | 109 | ||||
El-Ansary et al[65] | Not-randomized | 15 | HCV | MSCs | Peripheral vein |
Stem Cell Rev, 2012 | Vs untreated control | 10 control | CTP C | BM aspiration | 106 |
Peng et al[61] | Not-randomized | 53 | HBV | MSCs | Hepatic artery |
Hepatology, 2011 | Vs untreated control | 105 control | Mixed1 | BM aspiration | NA |
Couto et al[53] | Case series | 8 | Mixed | MNCs | Hepatic artery |
Liver Int, 2010 | CTP B-C | BM aspiration | 109 | ||
Nikeghbalian et al[58] | Case series | 6 | Mixed | MNCs/HSCs | Portalvein |
Arch Iran Med, 2011 | CTP C | BM aspiration | 106-109 | ||
Salama et al[66] | Randomized | 90 | HCV | HSCs | Portal vein |
World J Gastroenterol, 2010 | Vs untreated control | 50 control | NA | BM aspiration | 107 |
G-CSF | |||||
Kim et al[56] | Case series | 10 | HBV | MNCs | Peripheral vein |
Cell Transplantation, 2010 | MELD 7-13 | BM aspiration | 108/kg | ||
Lyra et al[62] | Randomized | 15 | Mixed | MNCs | Hepatic artery |
Eur J Gastroenterol Hepatol, 2009 | Vs untreated control | 15 control | CTP B-C | BM aspiration | 108 |
Kharaziha et al[67] | Case series | 8 | Mixed | MSCs | Portal vein |
Eur J Gastroenterol Hepatol, 2009 | MELD > 10 | BM aspiration | 108 | ||
Pai et al[63] | Case series | 9 | alcohol | HSCs | Hepatic artery |
AM J Gastroenterol, 2008 | CTP B | Leukapheresis | 108 | ||
G-CSF | |||||
Levicar et al[54] | Case series | 5 | Mixed | HSCs | Portalvein/ |
Cell Proliferat, 2008 | CTP A-B | Leukapheresis | hepaticartery | ||
G-CSF | 108 | ||||
Mohamadnejad et al[55] | Case series | 4 | Mixed | HSCs | Hepatic artery |
World J Gastroenterol, 2007 | CTP B-C | BM aspiration | 106-107 | ||
Lyra et al[70] | Case series | 10 | Mixed | MNCs | Hepatic artery |
World J Gastroenterol, 2007 | CTP B-C | BM aspiration | 108 | ||
Terai et al[44] | Case series | 9 | Mixed | MNCs | Peripheral vein |
Stem cells, 2006 | CTP B-C | BM aspiration | 109 |
In this study the patients had cirrhosis or chronic hepatitis. BMSC: Bone marrow stem cell; CTP :Child Turcotte Pugh score; MNC: Mononuclear stem cell; HSC: Hematopoietic stem cell; MSC: Mesenchymal stem cells; NA: Not available; GI: Gastrointestinal; Pt: Patients.